Lovastatin inhibits its own synthesis in Aspergillus terreus
- 23 January 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology and Biotechnology
- Vol. 31 (1) , 48-50
Abstract
Lovastatin suppresses its own synthesis in the microfungus Aspergillus terreus. The inhibitory effect was documented by spiking identical batch cultures with pure lovastatin (0, 50, 100 and 250 mg/l) 24 h after initiation from spores.Keywords
This publication has 13 references indexed in Scilit:
- Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite productionEnzyme and Microbial Technology, 2003
- Metabolic regulation of fermentation processesEnzyme and Microbial Technology, 2002
- Repeated fed-batch process for improving lovastatin productionProcess Biochemistry, 2000
- Production and purification of statins from Aspergillus terreus strainsBiotechnology Techniques, 1998
- Monitoring of selected metabolites and biotransformation products from fermentation broths by high-performance liquid chromatographyJournal of Chromatography A, 1997
- Secondary metabolites of the fungusMonascus: A reviewJournal of Industrial Microbiology and Biotechnology, 1996
- High-performance liquid chromatographic analysis of mevinolin as mevinolinic acid in fermentation brothsJournal of Chromatography A, 1995
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976